MWA Combined with TACE as a combined therapy for unresectable large-sized hepotocellular carcinoma

References

• Bosch FX, Ribes J, Borràs J. Epidemiology of primary liver cancer. Semin Liver Dis. 1999; 19(3)271–285, Review
   PubMed Web of Science ®Google Scholar
• Cabibbo G, Enea M, Attanasio M, Bruix J, Craxì A, Cammà C. A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma. Hepatology. 2010; 51(4)1274–1283
   PubMed Web of Science ®Google Scholar
• Shimada M, Yamashita Y, Hamatsu T, Rikimaru T, Hasegawa H, Gion T, Shirabe K, Takenaka K, Sugimachi K. Surgical indications for advanced hepatocellular carcinoma. Hepatogastroenterology. Jul–Aug, 2000; 47(34)1095–1099
   PubMedGoogle Scholar
• Takenaka K, Kawahara N, Yamamoto K, Kajiyama K, Maeda T, Itasaka H, Shirabe K, Nishizaki T, Yanaga K, Sugimachi K. Results of 280 liver resections for hepatocellular carcinoma. Arch Surg Jan, 1996; 131(1)71–76
   PubMed Web of Science ®Google Scholar
• Teh SH, Christein J, Donohue J, Que F, Kendrick M, Farnell M, Cha S, Kamath P, Kim R, Nagorney DM. Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: Model of End-Stage Liver Disease (MELD) score predicts perioperative mortality. J Gastrointest Surg 2005; 9: 1207–1215, discussion 1215
   PubMed Web of Science ®Google Scholar
• Benzoni E, Molaro R, Cedolini C, Favero A, Cojutti A, Lorenzin D, Intini S, Adani GL, Baccarani U, Bresadola F, et al. Liver resection for HCC: Analysis of causes and risk factors linked to postoperative complications. Hepatogastroenterology 2007; 54: 186–189
   PubMedGoogle Scholar
• Mok KT, Wang BW, Lo GH, Liang HL, Liu SI, Chou NH, Tsai CC, Chen IS, Yeh MH, Chen YC. Multimodality management of hepatocellular carcinoma larger than 10 cm. J Am Coll Surg. Nov, 2003; 197(5)730–738
   PubMed Web of Science ®Google Scholar
• Belghiti J, Kianmanesh R. Surgical treatment of hepatocellular carcinoma. HPB, 2005; 7: 42–49
   PubMedGoogle Scholar
• Llovet JM, Fuster J, Bruix J. The Barcelona approach: Diagnosis, staging and treatment of hepatocellular carcinoma. Liver Transplantation, 2004; 10: S115–S120
   Google Scholar
• Beaugrand M, Seror O. Transcutaneous treatments of hepatocellular carcinoma in patients with cirrhosis: Present status and future developments. Curr Pharm Des. 2007; 13(32)3274–3278
   PubMed Web of Science ®Google Scholar
• Wang ZL, Liang P, Dong BW, Yu XL, Yu DJ. Prognostic Factors and Recurrence of Small Hepatocellular Carcinoma after Hepatic Resection or Microwave Ablation: A Retrospective Study. J Gastrointest Surg. Feb, 2008; 12(2)327–337
   PubMed Web of Science ®Google Scholar
• Hinshaw JL, Lee FT, Jr. Cryoablation for liver cancer. Tech Vasc Interv Radiol. Mar, 2007; 10(1)47–57
   PubMedGoogle Scholar
• Marquet F, Pernot M, Aubry JF, Tanter M, Montaldo G, Fink M. In-vivo non-invasive motion tracking and correction in High Intensity Focused Ultrasound therapy. Conf Proc IEEE Eng Med Biol Soc. 2006; 1: 688–691
   Google Scholar
• Goldberg SN, Gazelle GS, Mueller PR. Thermal ablation therapy for focal malignancy: A unified approach to underlying principles, techniques, and diagnostic imaging guidance. AJR Am J Roentgenol 2000; 174: 323–331
   PubMed Web of Science ®Google Scholar
• Gazelle GS, Goldberg SN, Solbiati L, Livraghi T. Tumor ablation with radio-frequency energy. Radiology 2000; 217: 633–646
   PubMed Web of Science ®Google Scholar
• Farinati F, De Maria N, Marafin C, et al. Unresectable hepatocellular carcinoma in cirrhosis: Survival, prognostic factors, and unexpected side effects after transcatheter arterial chemoembolization. Dig Dis Sci 1996; 41: 2332–2339
   PubMed Web of Science ®Google Scholar
• Okada S. Transcatheter arterial embolization for advanced hepatocellular carcinoma: The controversy continues. Hepatology 1998; 27: 1743–1744
   PubMed Web of Science ®Google Scholar
• Pacella CM, Bizzarri G, Cecconi P, Caspani B, Magnolfi F, Bianchini A, Anelli V, Pacella S, Rossi Z. Hepatocellular carcinoma: Long-term results of combined treatment with laser thermal ablation and transcatheter arterial chemoembolization. Radiology 2001; 219: 669–678
   PubMed Web of Science ®Google Scholar
• Wu F, Wang ZB, Chen WZ, Zou JZ, Bai J, Zhu H, Li KQ, Jin CB, Xie FL, Su HB. Advanced hepatocellular carcinoma: Treatment with high-intensity focusedultrasound ablation combined with transcatheter arterial embolization. Radiology. May, 2005; 235(2)345–346
   PubMed Web of Science ®Google Scholar
• Zangos S, Eichler K, Balzer JO, Straub R, Hammerstingl R, Herzog C, Lehnert T, Heller M, Thalhammer A, Mack MG, et al. Large-sized hepatocellular carcinoma (HCC): A neoadjuvant treatment protocol with repetitive transarterial chemoembolization (TACE) before percutaneous MR-guided laser-induced thermotherapy (LITT). Eur Radiol. Feb, 2007; 17(2)553–563
   PubMed Web of Science ®Google Scholar
• Veltri A, Moretto P, Doriguzzi A, Pagano E, Carrara G, Gandini G. Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC). Eur Radiol. Mar, 2006; 16(3)661–669
   PubMed Web of Science ®Google Scholar
• Cabibbo G, Latteri F, Antonucci M, Craxì A. Multimodal approaches to the treatment of hepatocellular carcinoma. Nat Clin Pract Gastroenterol Hepatol. Mar, 2009; 6(3)159–169
   PubMedGoogle Scholar
• Giuseppe Cabibbo, Antonio Craxì. Needle track seeding following percutaneous procedures for hepatocellular carcinoma. World J Hepatol. Oct 31, 2009; 1(1)62–66
   PubMedGoogle Scholar
• Wang W, Shi J, Xie WF. Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: A meta-analysis. Liver Int. 2010; 30(5)741–749
   PubMed Web of Science ®Google Scholar
• Seki T, Wakabayashi M, Nakagawa T, Imamura M, Tamai T, Nishimura A, Yamashiki N, Okamura A, Inoue K. Percutaneous microwave coagulation therapy for patients with small hepatocellular carinoma: Comparison with percutaneous ethanol injection therapy. Cancer 1999; 85: 1694–1702
   PubMed Web of Science ®Google Scholar
• Shibata T, Iimuro Y, Yamamoto Y, Maetani Y, Ametani F, Itoh K, Konishi J. Small hepatocellular carcinoma: Comparison of radio-frequency ablation and percutaneous microwave coagulation therapy. Radiology 2002; 223: 331–337
   PubMed Web of Science ®Google Scholar
• Ren H, Liang P, Yu X, Wang Y, Lu T, Li X. Treatment of liver tumours adjacent to hepatic hilum with percutaneous microwave ablation combined with ethanol injection: A pilot study. Int J Hyperthermia.2011, 27(3)249–254
   Google Scholar
• Liu FY, Yu XL, Liang P, Wang Y, Zhou P, Yu J. Comparison of percutaneous 915 MHz microwave ablation and 2450 MHz microwave ablation in large hepatocellular carcinoma. Int J Hyperthermia.2010, 26(5)448–455
   Google Scholar
• Dong B, Liang P, Yu X, Su L, Yu D, Cheng Z, Zhang J. Percutaneous sonographically guided microwave coagulation therapy for hepatocellular carcinoma: Results in 234 patients. AJR 2003; 180: 1547–1555
   PubMed Web of Science ®Google Scholar
• Liang P, Dong B, Yu X, Yu D, Wang Y, Feng L, Xiao Q. Prognostic factors for survival in patients with hepatocellular carcinoma after percutaneous microwave ablation. Radiology 2005; 235: 299–307
   PubMed Web of Science ®Google Scholar
• Lu MD, Xu HX, Xie XY, Yin XY, Chen JW, Kuang M, Xu ZF, Liu GJ, Zheng YL. Percutaneous microwave and radiofrequency ablation for hepatocellular carcinoma: A retrospective comparative study. J Gastroenterol 2005; 40: 1054–1060
   PubMed Web of Science ®Google Scholar
• Seki T, Tamai T, Nakagawa T, Imamura M, Nishimura A, Yamashiki N, Ikeda K, Inoue K. Combination therapy with transcatheter arterial chemoembolization and percutaneous microwave coagulation therapy for hepatocellular carcinoma. Cancer. Sep 15, 2000; 89(6)1245–1251
   PubMed Web of Science ®Google Scholar
• The general rules for the clinical and pathological study of primary liver cancer. Liver Cancer Study Group of Japan. Jpn J Surg 1989;19:98–129
   Google Scholar
• Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, Morrow M. AJCC Cancer Staging Manual6th. Springer-Verlag, New York 2003
   Google Scholar
• Tancredi T, McCuskey PA, Kan Z, Wallace S. Changes in rat liver microcirculation after experimental hepatic arterial embolization: Comparison of different embolic agents. Radiology. Apr, 1999; 211(1)177–181
   PubMed Web of Science ®Google Scholar
• Yamakado K, Nakatsuka A, Ohmori S, Shiraki K, Nakano T, Ikoma J, Adachi Y, Takeda K. Radiofrequency ablation combined with chemoembolization in hepatocellular carcinoma: Treatment response based on tumor size and morphology. J Vasc Interv Radiol. Dec, 2002; 13(12)1225–1232
   PubMed Web of Science ®Google Scholar
• Liang P, Wang Y. Microwave ablation of hepatocellular carcinoma. Oncology. 2007; 72(Suppl 1)124–131
   PubMed Web of Science ®Google Scholar
• Iannitti DA, Martin RC, Simon CJ, Hope WW, Newcomb WL, McMasters KM, Dupuy D. Hepatic tumor ablation with clustered microwave antennae: The US Phase II Trial. HPB (Oxford)2007, 9(2)120–124
   PubMedGoogle Scholar
• Goldberg SN, Dupuy DE. Image-guided radiofrequency tumor ablation: Challenges and opportunities, part I. J Vasc Interv Radiol 2001; 12(9)1021–1032
   PubMed Web of Science ®Google Scholar
• Veltri A, Moretto P, Doriguzzi A, Pagano E, Carrara G, Gandini G. Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC). Eur Radiol. Mar, 2006; 16(3)661–669
   PubMed Web of Science ®Google Scholar
• Zangos S, Eichler K, Balzer JO, Straub R, Hammerstingl R, Herzog C, Lehnert T, Heller M, Thalhammer A, Mack MG, et al. Large-sized hepatocellular carcinoma (HCC): A neoadjuvant treatment protocol with repetitive transarterial chemoembolization (TACE) before percutaneous MR-guided laser-induced thermotherapy (LITT). Eur Radiol. Feb, 2007; 17(2)553–563
   PubMed Web of Science ®Google Scholar
• Wu F, Wang ZB, Chen WZ, Zou JZ, Bai J, Zhu H, Li KQ, Jin CB, Xie FL, Su HB. Advanced hepatocellular carcinoma: Treatment with high-intensity focused ultrasound ablation combined with transcatheter arterial embolization. Radiology. May, 2005; 235(2)659–667
   PubMed Web of Science ®Google Scholar
• keda K, Kumada H, Saitoh S, Arase Y, Chayama K. Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma. Cancer 1991; 68: 2150–2154
   PubMed Web of Science ®Google Scholar
• Bruix J, Castells A, Montanyà X, Calvet X, Brú C, Ayuso C, Jover L, García L, Vilana R, Boix L, et al. Phase II study of transarterial embolization in European patients with hepatocellular carcinoma: Need for controlled trials. Hepatology 1994; 20: 643–650
   PubMed Web of Science ®Google Scholar
• Llovet JM, Real MI, Montaña X, Planas R, Coll S, Aponte J, Ayuso C, Sala M, Muchart J, Solà R, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: A randomised controlled trial. Lancet 2002; 359: 1734–1739
   PubMed Web of Science ®Google Scholar
• Lo CM, Ngan H, Tso WK, Liu CL, Lam CM, Poon RT, Fan ST, Wong J. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology. 2002; 35: 1164–1171
   PubMed Web of Science ®Google Scholar
• Lim HS, Jeong YY, Kang HK, Kim JK, Park JG. Imaging features of hepatocellular carcinoma after transcatheter arterial chemoembolization and radiofrequency ablation. AJR Am J Roentgenol. Oct, 2006; 187(4)W341–349
   Google Scholar
• Junji Furuse. Sorafenib for the treatment of unresectable hepatocellular carcinoma. Biologics. Dec, 2008; 2(4)779–788
   PubMedGoogle Scholar